The Other (Tech-Heavy) Shoe
SAN FRANCISCO -- When does the other shoe drop? That's what everyone on Wall Street is mulling after the Dow Jones Industrial Average suffered another (steel-toed) booting on Tuesday.
By other big shoes, I'm not talking Ed Sullivan or even which company will be the next Procter & Gamble (PG Quote), which (of course) tumbled 30% after warning of lower-than-expected profits. Rather, the question on everyone's foot is when, if ever, the Dow's woes will begin to seriously affect the Nasdaq Composite. Sure, the Comp retreated from its intraday high of 5007.68, closing down 1.2% to 4864.84 today. But the index still looks pretty comfortable in its Manolo Blahniks. The Comp's gains were easier for Wall Street veterans to digest in recent years because the Dow also was on the march -- even if by smaller steps. The Nasdaq's ability to sustain itself this year even as the Dow has done an about-face has even its erstwhile critics in awe.Picks & Pans
While others pondered the unraveling of blue-chips and mulled the market's next turn, Richard Eakle, president of Eakle Associates, a Fair Haven, N.J, hedge fund and investment advisory service, believes he knows exactly where it's going: in the same direction. "The market will continue to perform in a bifurcated manner [and] continue to avoid commodity cyclicals and pay attention to technology," Eakle said in an interview today. Traditional value stocks will continue to suffer because "they have no pricing power, unit growth is slowing," and the dollar's strength will hamper their overseas profits, he argued. "I'm not at all surprised at what's happening in Procter & Gamble or Coca-Cola (KO Quote)," which slid 3.8% today in sympathy with P&G. Many consumer staples suffered similarly; the Morgan Stanley Consumer Index shed 5.3%. An economist used the term "creative destruction" to describe the transformation of an agrarian society into a manufacturing-based one at the end of the 19th century. A "similar evolutionary process" is taking place today in the shift from a manufacturing economy to a technology/information-focused one, Eakle believes. Thus, his roughly $65 million hedge fund is "heavily weighted" in biotech, Internet, software and certain financial stocks. The portfolio is up 53% so far this year, after gaining more than 300% in 1999, he claimed. A current favorite recommendation is Sirius Satellite Radio (SIRI Quote), a provider of digital-radio technology. The stock ran from the mid-20s late last year to close as high as 66 1/2 on Feb. 17, spurred by a $200 million investment from the Blackstone Group and news that DaimlerChrysler (DCX Quote) will begin to offer Sirius' technology beginning next year. Recent gains notwithstanding, "I don't think the story has been fully recognized for what it's worth," Eakle said. Today, the stock shed 7.7% to 60 3/8. Another favorite is Cerus (CERS Quote), which also leapt from the mid-20s in late 1999 to the high 60s in 2000. Today, shares of the blood-purification technology developer traded as high as 78 1/2 before closing at 70. "I'm reluctant to recommend it after the recent run-up," the hedge fund manager said, proving (at least) he's no Pollyanna. He would consider the stock very attractive if it retreated into the low 60s again. On the other side of the ledger, Eakle has about 15% of his assets in short positions, with current targets including Razorfish (RAZF Quote), Ask Jeeves (ASKJ Quote) and Intuit (INTU Quote). Eakle hasn't bothered shorting the Old Economy stocks he so loathes because "the exciting thing about being short is stocks go down three times faster than they go up." But watching value stocks, even if they're declining, is "like watching paint dry," he said. Obviously, he wasn't short P&G.P.S.
If Eakle's name rings a bell, it could be because he was at Morgan Stanley in 1987 and wrote a report saying the crash that October was a bottom, rather than the beginning of the end. Or maybe because his views are occasionally published in The Wall Street Journal and by TSC's own Herb Greenberg. Or maybe it's because he was the subject of a stinging Truth Serum piece on this site late last year. I encourage readers to check out that story and make up their own mind. All I can say is Eakle was clearly rankled by that story (and said as much) and could have easily found me guilty by association and dismissed my inquiries. To his credit, he didn't -- although a lot of other folks in this business would have (and do).- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,300.10 | 1,094.31 | 2,171.97 | 33.64 |
Oil *
75.71
|
|
DOWN
90.01
|
DOWN
8.94
|
DOWN
17.64
|
DOWN
0.84
|
10 Yr
3.36%
SPDR Gold
113.11
|
|
-0.87%
|
-0.81%
|
-0.81%
|
-2.44%
|
Data delayed 20 minutes |














